Chief Executive Officer
Meg Smith was named Chief Executive Officer of Cure Alzheimer’s Fund effective October 1st, 2023, after eight years of successfully building and managing the research program and serving in increasing levels of leadership, most recently as Executive Vice President, Research Management. Meg joined Cure Alzheimer’s Fund as Senior Advisor, Strategy and Special Projects, in 2015 and was promoted to Executive Vice President, Research Management, in 2021.
Through Meg’s stewardship of our research funding program, Cure Alzheimer’s Fund has made $138 million in research grants—nearly 80% of total distributions since our founding in 2004. This funding has resulted in enormous progress and remarkable discoveries from our scientists. Meg’s leadership and guidance has also helped to inspire an impressive 7.5X in follow-on funding from the National Institutes of Health, multiplying our impact with the progress of Alzheimer’s disease research and our mission. All of this is a direct result of the standard of excellence that Meg has brought to the CureAlz research funding process.
Previously, Meg was with McKinsey & Company after clerking for the Massachusetts Supreme Judicial Court and serving as a Fellow at the Berkman (now Berkman Klein) Center for Internet & Society at Harvard Law School. Meg holds a juris doctor degree from Harvard Law School and a bachelor of science degree from Duke University.
